UK Spine Biologics Market Size & Outlook, 2023-2030

The spine biologics market in UK is expected to reach a projected revenue of US$ 216.8 million by 2030. A compound annual growth rate of 5.7% is expected of UK spine biologics market from 2024 to 2030.
Revenue, 2023 (US$M)
$147.1
Forecast, 2030 (US$M)
$216.8
CAGR, 2024 - 2030
5.7%
Report Coverage
UK

UK spine biologics market highlights

  • The UK spine biologics market generated a revenue of USD 147.1 million in 2023 and is expected to reach USD 216.8 million by 2030.
  • The UK market is expected to grow at a CAGR of 5.7% from 2024 to 2030.
  • In terms of segment, spinal allografts was the largest revenue generating product in 2023.
  • Cell-based Matrix is the most lucrative product segment registering the fastest growth during the forecast period.


Spine biologics market data book summary

Market revenue in 2023USD 147.1 million
Market revenue in 2030USD 216.8 million
Growth rate5.7% (CAGR from 2023 to 2030)
Largest segmentSpinal allografts
Fastest growing segmentCell-based Matrix
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSpinal Allografts, Bone Graft Substitutes, Cell-based Matrix
Key market players worldwideStryker Corp, NuVasive, Orthofix Medical Inc, DePuy Synthes, Exactech, Zimmer Biomet Holdings Inc, Arthrex, Medtronic PLC, Organogenesis, Kuros Biosciences Ltd


Other key industry trends

  • In terms of revenue, UK accounted for 4.8% of the global spine biologics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany spine biologics market is projected to lead the regional market in terms of revenue in 2030.
  • France is the fastest growing regional market in Europe and is projected to reach USD 217.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Spine Biologics Market Companies

Name Profile # Employees HQ Website

UK spine biologics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to spine biologics market will help companies and investors design strategic landscapes.


Spinal allografts was the largest segment with a revenue share of 58.8% in 2023. Horizon Databook has segmented the UK spine biologics market based on spinal allografts, bone graft substitutes, cell-based matrix covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to UK spine biologics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UK spine biologics market databook

  • Our clientele includes a mix of spine biologics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UK spine biologics market, including forecasts for subscribers. This country databook contains high-level insights into UK spine biologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UK spine biologics market size, by product, 2018-2030 (US$M)

UK Spine Biologics Market Share, 2023 & 2030 (US$M)

UK spine biologics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more